Dr. Ziegner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1970 South Prospect Ave
Ste #3
Redondo Beach, CA 90277Phone+1 310-792-9050Fax+1 310-792-9048
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterPost-Doctoral Fellowship, Allergy and Immunology, 1999 - 1999
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Allergy/Immunology, 1997 - 1999
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1994 - 1997
- UPMC Childrens Hospital of Pittsburgh Primary Care CenterPost-Doctoral Fellowship, 1987 - 1991
- Internal MedicineResidency, Department of Cardiology and Department of Oncology/Immunology, 1985 - 1987
- Institut für PathologieResidency, Pathology, 1984 - 1985
- Univ Cologne- Fac MedClass of 1984, MD
- School for Medical TechnologistsTechnologist, Medical Laboratory , 1973 - 1976
- University of BochumPhysical, Anorganic and Organic Chemistry, 1972 - 1973
Certifications & Licensure
- CA State Medical License 1996 - 2026
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
- Fellow (FACAAI) American College of Allergy Asthma and Immunology, 2004
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology, 2004
- Join now to see all
Clinical Trials
- A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma Start of enrollment: 2004 Jun 01
- Efficacy and Safety of Two Dry Power Inhalers (DPIs) Used for the Application of Mometasone in the Treatment of Asthma Start of enrollment: 2002 Oct 01
- A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy Start of enrollment: 2010 May 01
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsDeficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection.Ulrike Ziegner, Donald E. Campbell, Kent J. Weinhold, Ian Frank, Richard M. Rutstein
Clinical and Diagnostic Laboratory Immunology. 1999-09-01 - 48 citationsProgressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment.Ulrike H.M. Ziegner, Roger H. Kobayashi, Charlotte Cunningham-Rundles, Teresa Espanol, Anders Fasth
Clinical Immunology. 2002-01-01 - 12 citationsMurine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization.Chad A. Dickey, Ulrike H.M. Ziegner, P Michael G. Agadjanyan, Vasantha Srikantan, Yosef Refaeli
DNA and Cell Biology. 2000-04-01
Lectures
- Cutaneous Drug Reactions.Torrance Memorial Medical Center, 4th Annual Children’s Nursing Symposium
- Primary Immunodeficiencies.Torrance Memorial Medical Center, Torrance, Pediatric Grand Rounds
- Childhood Immunizations.Beach Cities Parents of Multiples Association (BCPMA)
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- French, German, Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: